Platform Company
Unlocking the value of medical imaging
Quibim is a global healthtech company pioneering AI-powered imaging biomarkers for precision medicine.
We turn routine medical images (MRI, CT, and PET), alongside molecular and clinical data, into quantitative, actionable insights across oncology, neurology, immunology and metabolic diseases. Through value-based partnerships with biopharma, we help drug developers identify the right patients, monitor response and accelerate their programs. Through regulated software-as-a-medical-device, we bring hospitals standardized, decision-ready evidence that supports more consistent and confident clinical decisions.
- 0 +sites working with Quibim products worldwide
- 0 K+de-identified cancer patients registry
- 0 M+de-identified research imaging dataset
- 0 +publications in high impact factor journals
- 0of the top 20 pharma companies working with us
- 0 +active clinical studies
End-to-end AI platform for precision medicine
QP-Insights®, our proprietary platform, is the engine beneath every product and partnership: one validated AI platform that carries imaging the whole way, from a biomarker in a scan to a regulatory-cleared product.
Built on Quibim’s proprietary datasets and foundational models, QP-Insights® enables faster, more precise, and scalable insights to understand disease as never before, helping clinicians make more informed, patient-centered decisions that improve outcomes and quality of care.
To translate research into clinical practice, Quibim combines its core platform with in-house quality and regulatory, commercial and market access expertise to take innovations through development, regulatory clearance, launch, and clinical adoption.
From Imaging Biomarker Discovery to Regulatory-cleared Products
Inside QP-Insights®: Where Imaging Becomes Evidence
Radiomics is at the core of our platform: a technology that extracts detailed quantitative disease-specific insights from routine medical images. QP-Insights®, Quibim’s proprietary platform, builds on this foundation to develop and validate AI models that support diagnosis, prognosis, and prediction of treatment response for more personalized care.
QP-Insights® carries imaging all the way to actionable evidence. The same platform connects image acquisition, quantitative analysis, model development, validation, and real-world application, bringing imaging insights to clinicians, researchers, and pharma teams.
Explore here our interactive infographic
QP-Insights® Cloud Infrastructure
A secure, cloud-based infrastructure built to bring imaging, multi-omics, and clinical data together.
QP-Insights® centralizes, manages, harmonizes, and processes medical imaging at scale, integrating AI-powered solutions and data workflows from image acquisition through analysis and reporting.
Fully web-based, allowing centralization of imaging studies, multi-omics and clinical data:
- Ensures end-to-end data protection with encryption applied both at rest and in transit.
- Supports full de-identification of patient data
- Able to integrate with local PACS to enable automatic transfer of images and reports via QP-Link (Quibim’s connector)
- Manages, indexes, and stores multi-omics data
- Real-time data QC and radiological readings
- Fully automated quantification of imaging biomarkers
- Structured quantitative reports delivered directly to PACS
- Customizable based on user requirements
- ISO 27001 certified
- HIPAA and GDPR compliant
Read more about our legal & data security measures here.
